Featuring the world's longest projected longevity.1–4
Platinium™ 4LV CRT-D is small in design with no compromise on longevity.
Featuring
Parad+™
World's first dual-chamber discrimination algorithm.
Featuring
BTO™
Brady-Tachy OverlapTM is the world’s only CRT-D technology allowing pacing therapy during exercise.
More LV vectors for flexible pacing
- Multiple choice among 14 LV vectors
- Reduced risk of phrenic nerve stimulation5
- Lower pacing threshold5
Dedicated LV test assistant for quick LV pacing selection
- Automatic sequential testing
- Results on all vectors at a glance
- Previous test data included
World's longest longevity1–4
10.9-year longevity.
Longevity is based on real life pacing conditions.6
Backed by warranty.7
Extended 7-year warranty.
Warranty applies regardless of the pacing conditions and therapy frequency.7
Breakthrough technology that stands the test of time.
- 40% reduced electronic consumption8
- 20% improved battery capacity8
- Reforming-free capacitors mean zero energy is wasted
Protect your patients from replacements.
The time has come to close the gap between patient life expectancy and device longevity.
84% of patients would not need a replacement if their device were to last more than 9 years.9
Visit the Cardiac Device Longevity website for more information.
Small size
PlatiniumTM is designed to facilitate the implant experience and improve patient comfort.
- Rounded edges
- Reduced pocket size
- Allows for smaller incision
- Better fit for replacements
Ergoform™ design
PlatiniumTM with its smooth and curved header is designed for natural lead wrap around.
Parad+™
Protecting patients for over 20 years.
- World’s first dual-chamber discrimination algorithm
- Best in class 99% specificity10
- Low inappropriate shock rate11
- Immediate protection with PARAD+TM out-of-the-box setting*
BTO™
Active resynchronization.
The world’s only CRT-D device allowing Brady-Tachy OverlapTM.
BTOTM:
- Ensures resynchronization whatever the patients’ condition
- Detects and treats VT with painless therapy
- Delivers CRT pacing during exercise for cardiac rehabilitation
- 96% specificity in slow VT zone12
- A proof of PARAD+TM discrimination performance
*Not applicable to USA devices.
This product may not be for sale in your country or your area. For further information on product availability, please contact your local representative.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For indications, contraindications, precautions and warnings for each device, please refer to the product manual.
References
- Medtronic. CLARIA MRI™ QUAD CRT-D SureScan™ DTMA2QQ Device manual M956980A001 B 2017-07-17.
- (EU) Biotronik. ILIVIA™ 7 VR-T, VR-T DX, DR-T, HF-T, HF-T QP (ProMRI®) Technical Manual 417641 Revision: D (2016-08-09).
(US) Biotronik. ILIVIA ProMRI™ Family of ICDs and CRT-Ds. Technical Manual M4206-B 01/18/MN070 1/23/18. - (EU) Saint Jude Medical – Bradycardia and Tachycardia Devices – Help Manual – June 2013 Art 60033180/A.
(US) Saint Jude Medical. Bradycardia and Tachycardia Devices Help Manual. 2017 ARTEN100161329 A. - (EU) Physician’s technical manual RESONATE™ HF CRT-D, RESONATE™ CRT-D, RESONATE™ X4 CRT-D, CHARISMA™ CRT-D, CHARISMA™ X4 CRT-D, VIGILANT™ CRT-D, VIGILANT™ X4 CRT-D, MOMENTUM™ CRT-D, MOMENTUM™ CRT-D X4 – Cardiac Resynchronization Therapy Defibrillator 360203-001 EN Europe 2016-09.
(US) Boston Scientific. Physician’s technical manual AUTOGEN™ CRT-D, AUTOGEN™ X4 CRT-D, DYNAGEN™ CRT-D, DYNAGEN™ X4 CRT-D, INOGEN™ CRT-D, INOGEN™ X4 CRT-D, ORIGEN™ CRT-D, ORIGEN™ X4 CRT-D, INCEPTA™ CRT-D, ENERGEN™ CRT-D, PUNCTUA™ CRT-D, COGNIS™ 100-D CRT-D – Cardiac Resynchronization Therapy Defibrillator – 359401-004 EN US 2017-04. - Oswald H, et al. Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients with Quadripolar LV Leads: The EffaceQ Study. Pacing Clin Electrophysiol. 2015;38:942–50.
- Functioning conditions for projected longevity (conditions based on MicroPort CRM data on file): CRT-D models: Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60min-1, 600Ω, A & RV pacing amplitude 2.5V, LV pacing amplitude 3V, 0.35ms, 3 max shocks per year, sensor OFF. Longevity is calculated by taking into account 6 months storage with the following conditions: Remote ON: daily check, 4 follow-ups and 5 full alert reports per year. RF telemetry ON: 120min at implant + 15min at discharge + 15min in-clinic quarterly FU.
- (EU) Product manual. U666 – LIMITED WARRANTY for PLATINIUM ICD & CRT-D devices.
(US) Product manual. U668 – LIMITED WARRANTY for PLATINIUM ICD & CRT-D devices. - Versus previous CRT-D generation (Paradym RF). Manual available at www.microportmanuals.com
- Ramachandra I. Impact of ICD battery Longevity on Need for Device Replacements-Insight from Veterans Affairs Database. PACE. 2010;33:314–19.
- Hintringer F, et al. Comparison of the Specificity of Implantable Dual Chamber Defibrillator Detection Algorithms. Pacing Clin Electrophysiol 2004;27:976–82.
- Kolb C, et al. Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy. Results of the randomized Option study. JACC Heart Fail. 2014;2:611–19.
- Sadoul N, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation. 2005;112:946–53.